OTC Markets EXMKT - Delayed Quote USD

Bonus BioGroup Ltd. (BBIXF)

Compare
0.0200 0.0000 (0.00%)
At close: December 13 at 3:00:00 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Joseph Rauch M.B.A. Executive Chairman of the Board 1.5M -- 1957
Dr. Shai Meretzki Ph.D. Founder, CEO, President & Director 1.98M -- 1969
Mr. Yoni Livne CPA Chief Financial Officer 730k -- 1975
Dr. Dror Ben David Ph.D. Chief Operations Officer 600k -- 1977
Dr. Vered Kivity M.B.A., Ph.D. Head of Regulatory Affairs & VP of Clinical Affairs -- -- --

Bonus BioGroup Ltd.

20 Madain Industries Center
POB 15143
Haifa, 3190501
Israel
972 7 3206 7100 https://bonus-bio.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
58

Description

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.

Corporate Governance

Bonus BioGroup Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

ENLV.TA Enlivex Therapeutics Ltd.
428.30
-6.10%
 
MOLN Molecular Partners AG
5.43
-0.55%
 
HUMAW Humacyte, Inc.
1.3900
-6.71%
 
ARMP Armata Pharmaceuticals, Inc.
2.1918
+4.37%
 
INVA Innoviva, Inc.
18.58
+0.16%
 
GBIO Generation Bio Co.
1.1600
-2.52%
 
LENZ LENZ Therapeutics, Inc.
30.97
+0.62%
 
HCWB HCW Biologics Inc.
0.3570
-7.75%
 
ENLV Enlivex Therapeutics Ltd.
1.2000
-0.83%
 
LTRN Lantern Pharma Inc.
3.4450
-5.10%